H.R. 4981 (119th)Bill Overview

Stamp Out Lyme Disease Act

Health|Health
Cosponsors
Support
Bipartisan
Introduced
Aug 15, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the Committee on Oversight and Government Reform, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, i…

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill directs the United States Postal Service to issue a Lyme Disease Research Semipostal Stamp under 39 U.S.C. §416. Proceeds from the sale of the stamp are to be transferred at least twice a year to the National Institute of Allergy and Infectious Diseases (NIAID) for Lyme disease and related tick-borne illness research, and those proceeds shall not be counted against NIAID’s federal appropriations.

Why people may split

Degree of enthusiasm: progressive most enthusiastic, conservative more cautious but not opposed.

Watch point

Relative to its intended legislative type, this bill is a concise and legally integrated administrative measure that authorizes and prescribes key parameters for a Lyme Disease Research semipostal stamp by leveraging existing semipostal statute.

The bill directs the United States Postal Service to issue a Lyme Disease Research Semipostal Stamp under 39 U.S.C. §416.

Proceeds from the sale of the stamp are to be transferred at least twice a year to the National Institute of Allergy and Infectious Diseases (NIAID) for Lyme disease and related tick-borne illness research, and those proceeds shall not be counted against NIAID’s federal appropriations.

The stamp must be made available to the public for at least six years and issued no later than 12 months after enactment.

Passage70/100

On content alone this is a narrow, administratively straightforward bill to raise voluntary funds for disease research via an existing semipostal mechanism. It has low ideological salience and limited fiscal impact, which historically makes enactment more probable than major policy bills. The principal risks are procedural (Senate floor access), possible concerns about bypassing appropriations norms or setting a precedent for directed non-appropriated transfers, and any USPS regulatory or operational considerations.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a concise and legally integrated administrative measure that authorizes and prescribes key parameters for a Lyme Disease Research semipostal stamp by leveraging existing semipostal statute.

Contention30/100

Degree of enthusiasm: progressive most enthusiastic, conservative more cautious but not opposed.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Federal agencies · ConsumersCities · Federal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Federal agenciesCreates a dedicated, voluntary revenue stream to supplement federal funding for Lyme disease and tick-borne illness res…
  • ConsumersMay raise public awareness about Lyme disease and tick-borne illnesses through publicity and consumer purchase of the t…
  • Federal agenciesBecause proceeds are designated as additional and not to be offset against appropriations, the mechanism could increase…
Likely burdened
  • CitiesRevenue from a semipostal stamp is likely to be modest relative to the overall scale of Lyme disease research needs, so…
  • Potential burdenIssuing and marketing a semipostal stamp creates administrative and production costs for the USPS and requires program…
  • Federal agenciesDirecting proceeds to a specific federal research program via a postal fundraising mechanism may raise concerns that re…
03 · Why people split

Why the argument around this bill splits.

Degree of enthusiasm: progressive most enthusiastic, conservative more cautious but not opposed.
Progressive90%

This persona would generally view the bill favorably because it creates a voluntary, public-facing funding stream for research on a disease that is described as common, costly, and sometimes long-lasting.

They will appreciate that proceeds go to NIAID and that transfers are not to be offset against appropriations, which could increase research funding.

They may also want assurance that funds address inequities in diagnosis and care, and that research addresses persistent/post‑treatment conditions and prevention, including vector control and climate-related spread.

Leans supportive
Centrist75%

A centrist/moderate would likely view this bill as a pragmatic, low-cost, voluntary approach to raise targeted research funds without mandating new taxation or large appropriations.

They would welcome the statutory prohibition on offsetting appropriations but want clarity on expected revenue, administrative costs, and accountability for how funds are spent.

Centrists will balance support for public health research with scrutiny toward effectiveness and the potential for creating unfunded or poorly overseen programs.

Leans supportive
Conservative60%

A mainstream conservative would likely be open to the bill because it uses a voluntary, market-like mechanism (a semipostal stamp) rather than new taxes or large new federal programs.

They may appreciate that funds are generated by public choice and that the mechanism leverages an existing Postal Service authority.

However, they will be attentive to concerns about government research priorities, potential expansion of federal involvement in medical research, and whether the Postal Service should be used for what some may view as an advocacy or fundraising role.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood70/100

On content alone this is a narrow, administratively straightforward bill to raise voluntary funds for disease research via an existing semipostal mechanism. It has low ideological salience and limited fiscal impact, which historically makes enactment more probable than major policy bills. The principal risks are procedural (Senate floor access), possible concerns about bypassing appropriations norms or setting a precedent for directed non-appropriated transfers, and any USPS regulatory or operational considerations.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • The bill does not estimate expected revenue from the semipostal stamp; the magnitude of funds and whether they are seen as material enough to justify congressional action is unknown.
  • Potential procedural hurdles in the Senate (floor time, objection to non-appropriated transfers, or resistance to setting precedent for semipostals) are unknown and could affect final passage despite low substantive controversy.
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Degree of enthusiasm: progressive most enthusiastic, conservative more cautious but not opposed.

On content alone this is a narrow, administratively straightforward bill to raise voluntary funds for disease research via an existing semi…

Unlocked analysis

Relative to its intended legislative type, this bill is a concise and legally integrated administrative measure that authorizes and prescribes key parameters for a Lyme Disease Research semipostal stamp by leveraging ex…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis